11 Eye. To be used in conjunction with NICE guidance/guidelines, the British National Formulary for adults and/or children, and

Size: px
Start display at page:

Download "11 Eye. To be used in conjunction with NICE guidance/guidelines, the British National Formulary for adults and/or children, and"

Transcription

1 11 Eye To be used in conjunction with NICE guidance/guidelines, the British National Formulary for adults and/or children, and The Royal College of Ophthalmologists guidelines Index 11.1 Administration of drugs to the eye 11.2 Control of microbial contamination 11.3 Anti-infective eye preparations 11.4 Corticosteroids and other anti-inflammatory preparations 11.5 Mydriatics and cycloplegics 11.6 Treatment of glaucoma 11.7 Local anaesthetics 11.8 Miscellaneous ophthalmic preparations 11.9 Contact lenses

2 11.1 Administration of drugs to the eye BNF notes on the administration of drugs to the eye Return to index

3 11.2 Control of microbial contamination BNF notes on the control of microbial contamination Return to index

4 11.3 Anti-infective eye preparations BNF notes on antifungals DRUG BRAND / FORMULATION NOTES Antibacterials Azithromycin dihydrate Chloramphenicol Ciprofloxacin Fusidic acid Gentamicin Levofloxacin Moxifloxacin Azyter 0.5% eye drops 10 ml 0.5% preservative-free eye drops 10 ml 0.5% eye drops single-use units x20 1% eye ointment 4 g 0.3% eye drops 5 ml 1% eye drops 5 g 0.3% eye drops 10 ml Gentamicin forte 1.5% preservative-free eye drops 10 ml 0.5% eye drops 5 ml 0.5% preservative-free eye drops single-use units x30 Moxivig

5 Neomycin sulfate Ofloxacin Propamidine isetionate Tobramycin Neomycin 0.3% eye drops 5 ml Brolene Tobravisc Antifungals Clotrimazole 1% preservative-free eye drops 10 ml Antivirals Aciclovir Ganciclovir Trifluorothymidine 3% eye ointment 4.5 g 0.15% ophthalmic gel 5 g 1% preservative-free eye drops 10 ml Return to index

6 11.4 Corticosteroids and other anti-inflammatory preparations NICE guidance on dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion Corticosteroids Betamethasone Betamethasone with neomycin Dexamethasone Dexamethasone with antibacterials Fluorometholone Hydrocortisone acetate Loteprednol etabonate Prednisolone 0.1% eye ointment 3 g Betnesol-N 0.1% eye drops 5 ml / 10ml 0.1% eye drops single-use units x20 (Maxitrol) Dexamethasone 0.1%/neomycin 0.35%/polymixin B sulphate 600 units/ml eye drops 5 ml (Maxitrol) Dexamethasone 0.1%/neomycin 0.35%/polymixin B sulphate 600 units/g eye ointment 3.5 g (Tobradex) Dexamethasone 0.1%/tobramycin 0.3% eye drops 5 ml 0.1% eye drops 5 ml / 10ml Hydrocortisone 0.5% eye drops 5 ml 0.5% eye drops 10 ml 0.5% eye drops single-use units x20

7 1% eye drops 5 ml / 10ml Rimexolone 1% eye drops 5 ml Intravitreal corticosteroids Dexamethasone 700 micrograms intravitreal injection Ozurdex As per NICE only (see link above) Other anti-inflammatory preparations Antazoline sulfate Azelastine hydrochloride Emedastine Epinastine hydrochloride Ketotifen Lodoxamide Nedocromil sodium Olopatadine Sodium cromoglicate (Otrivine-Antistin) Xylometazoline 0.05%/antazoline 0.5% eye drops 10 ml Optilast Emadine Relestat Zaditen 0.1% eye drops 10 ml 2% eye drops 5 ml Rapitil 1 mg/ml eye drops 5 ml Opatanol 2% eye drops 13.5 ml Catacrom

8 Return to index

9 11.5 Mydriatics and cycloplegics Antimuscarinics Atropine sulfate Cyclopentolate hydrochloride Homatropine hydrobromide Tropicamide Tropicamide with phenylephrine 1% eye drops 10 ml 1% preservative-free eye drops 10 ml 1% eye drops single-use units x20 0.5% eye drops 5 ml 0.5% eye drops single-use units x20 1% eye drops 5 ml 1% eye drops single-use units x20 Homatropine Mydriacyl 0.5% & 1% eye drops single-use units x20 See sympathomimetics, below Sympathomimetics Phenylephrine hydrochloride Phenylephrine hydrochloride with tropicamide 2.5% & 10% eye drops single-use units x20 Mydriasert Return to index

10 11.6 Treatment of glaucoma NICE quality standard for glaucoma NICE guideline on the diagnosis and management of chronic open angle glaucoma and ocular hypertension Beta-blockers Betaxolol Carteolol hydrochloride Levobunolol hydrochloride Timolol Timolol with bimatoprost Timolol with brimonidine Timolol with brinzolomide Timolol with dorzolamide Timolol with latanoprost 0.25% suspension eye drops 5 ml 0.5% eye drops 5 ml Carteolol 1% & 2% eye drops 5 ml 0.5% eye drops 5 ml 0.5% preservative-free eye drops single-use units x % & 0.5% eye drops 5 ml 0.5% preservative-free eye drops single-use units x % long acting eye drops 2.5 ml See prostaglandin analogues and prostamides, below See sympathomimetics, below See carbonic anhydrase inhibitors and systemic drugs, below See carbonic anhydrase inhibitors and systemic drugs, below See prostaglandin analogues and prostamides, below

11 Timolol with travoprost See prostaglandin analogues and prostamides, below Prostaglandin analogues and prostamides Bimatoprost Bimatoprost with timolol Latanoprost Latanoprost with timolol Tafluprost Travoprost Travoprost with timolol 0.01% & 0.03% eye drops 3 ml (Ganfort) Bimatoprost 0.3 mg/timolol 5 mg/ml eye drops 3 ml 50 micrograms/ml eye drops 2.5 ml Xalatan Latanoprost with Timolol (Xalacom) Latanoprost 0.005%/timolol 0.5% eye drops 2.5 ml 15 micrograms/ml eye drops single-use units x30 40 micrograms/ml eye drops 2.5 ml (DuoTrav) Travoprost 40 micrograms/timolol 5 mg/ml eye drops 2.5 ml Sympathomimetics Brimonidine tartrate Brimonidine tartrate with timolol 0.2% eye drops 5 ml (Combigan) Brimonidine 0.2%/timolol 0.5% eye drops 5 ml Carbonic anhydrase inhibitors and systemic drugs Acetazolamide 250 mg tablets x mg injection vial

12 250 mg sustained release capsules x 30 Brinzolamide Brinzolamide with timolol Dorzolamide Dorzolamide with timolol 10 mg/ml eye drops 5 ml (Azarga) Brinzolamide 10 mg/timolol 5 mg/ml eye drops 5 ml 2% eye drops 5 ml 2% preservative-free eye drops single-use units x60 Dorzolamide with Timolol (Cosopt) Dorzolamide 2%/timolol 0.5% eye drops 5 ml (Cosopt) Dorzolamide 2%/timolol 0.5% preservativefree eye drops single-use units x60 Miotics Pilocarpine 1%, 2% & 4% eye drops 10 ml 2% preservative-free eye drops 10 ml 2% eye drops single-use units x20 Return to index

13 11.7 Local anaesthetics Local anaesthetics Cocaine Lidocaine hydrochloride with fluorescein Oxybuprocaine hydrochloride Proxymetacaine hydrochloride Proxymetacaine hydrochloride with fluorescein Tetracaine hydrochloride 4% preservative-free eye drops 2 ml Lidocaine 4%/fluorescein 0.25% eye drops single-use units x20 0.4% eye drops single-use units x20 0.5% eye drops single-use units x20 Proxymetacaine 0.5%/fluorescein 0.25% eye drops single-use units x20 0.5% & 1% eye drops single-use units x20 Return to index

14 11.8 Miscellaneous ophthalmic preparations NICE guidance on ranibizumab and pegaptanib for the treatment of age-related macular degeneration NICE recommends ranibizumab for the treatment of diabetic macular oedema Tear deficiency, ocular lubricants, and astringents Acetylcysteine Carbomers Carmellose sodium Hydroxyethylcellulose Hydroxypropyl guar (Ilube) Acetylcysteine 5%/hypromellose 0.35% eye drops 10 ml Clinitas Gel GelTears Liposic Liquivisc Lumecare Long Lasting Tear Gel (Viscotears) Carbomer % eye drops 10 g (Viscotears) Carbomer % preservative-free eye drops single-use units x30 (Optive) Carmellose 0.5% in glycerol eye drops 10 ml Carmellose 0.5% & 1% eye drops single-use units x30 (Artificial Tears) 0.44% eye drops single-use units x20 (Systane) Hydroxypropyl guar 0.2% eye drops 10 ml Systane Ultra (Systane) Hydroxypropyl guar 0.2% preservative-free eye drops single-use units x28

15 Hypromellose Liquid paraffin Paraffin, yellow, soft Polyvinyl alcohol Sodium chloride Hypromellose 0.3% eye drops 10 ml Artelac Isopto Alkaline Isopto Plain Tear-Lac (Tears Naturale) Dextran %/hypromellose 0.3% eye drops 15 ml Hypromellose 0.3% preservative-free eye drops single-use units x30 Artelac SDU single use Hydromoor single use Lumecare Preservative Free Tear Drops single use Tears Naturale Single Dose Lacri-Lube eye ointment 3.5 g VitA-POS Simple Eye Ointment 4g Polyvinyl alcohol 1.4% eye drops 15 ml Liquifilm Tears Sno Tears Sodium chloride 0.9% eye drops single-use units x20 Sodium chloride 0.9% eye lotion 500 ml Sodium chloride 5% eye drops 10 ml Sodium chloride 5% eye ointment 5 g Sodium chloride 5% preservative-free eye drops 10 ml Balanced Salt Solution singles 19 ml

16 Sodium hyaluronate Balanced Salt Solution 500 ml bag x6 Balanced Salt Solution Plus 500 ml bottle Sodium hyaluronate 0.1% preservative-free eye drops 10 ml Sodium hyaluronate 0.2% preservative-free eye drops 10 ml Hyabak Hylo-Care Hylo-Forte Hylo-Tear Oxyal Vismed Multi Clinitas single use Lubristil single use Ocusan single use Vismed single use Vismed Gel single use Ocular diagnostic and peri-operative preparations and photodynamic treatment ocular diagnostic preparations Fluorescein sodium Fluorescein sodium with local anaesthetic Fluorescein 1% & 2% eye drops single-use units x20 Fluorescein 1 mg ophthalmic strips x100 Fluorescein 20% 5 ml injection ampoules x 5 / 10 See section 11.7 Local anaesthetics, above Ocular diagnostic and peri-operative preparations and photodynamic treatment ocular peri-operative drugs

17 Acetylcholine chloride Apraclonidine Bromfenac Diclofenac sodium Flurbiprofen sodium Ketorolac trometamol Nepafenac 20 mg intra-ocular injection 2 ml vial with diluent 0.5% eye drops 5 ml 1% eye drops single-use units 12 x 2 Yellox 0.1% eye drops single-use units x40 Ocufen 0.5% eye drops 5 ml Nevanac Ocular diagnostic and peri-operative preparations and photodynamic treatment subfoveal choroidal neovascularisation Pegaptanib sodium Macugen As per NICE only (see links above) Ranibizumab Ranibizumab 2.3 mg/0.23 ml intravitreal injection vial Lucentis As per NICE only (see links above) Verteporfin Verteporfin 15 mg injection vial Visudyne Miscellaneous Alteplase Ciclosporin Ciclosporin A 100 micrograms/0.1 ml intravitreal injection 2 ml vial 500 micrograms/2 ml intravitreal injection kit 0.06% preservative-free eye drops 10 ml 0.2% eye ointment 3.5 g

18 Disodium edetate Glycerol Hydroxypropyl methylcellulose IML blue solution Lissamine green Membrane Blue Mydricaine Oxane oil Perfluoradecalin heavy liquid Perfluoroctane liquid Polihexanide Potassium ascorbate Povidone iodine Silicone oil Sodium hyaluronate Trypan 0.37% eye drops 10 ml 0.37% sterile solution 20 ml 2% intra-ocular injection 2.5 ml syringe (Visicrom) 0.5 ml vials x 5 (Brilliant Peel) ophthalmic strips x100 sterile injection 0.5 ml dual syringe x5 No ml injection ampoules x ml vial 5 ml vial 5 ml vial 0.02% preservative-free eye drops 10 ml 10% preservative-free eye drops 10 ml 5% preservative-free eye drops 10 ml 2000 CPS 10 ml 5000 CPS 10 ml (Siluron) 1% & 1.2% intra-ocular injection 1 ml syringe 0.5 ml sterile solution vial x10 (Vision Blue) Return to index

19 11.9 Contact lenses BNF notes on contact lenses Miscellaneous contact lens preparations Eye drops Contact lense solutions Blink Contacts eye drops multi-dose bottle 10 ml Blink Contacts eye drops single-use units x20 Physiological saline preservative-free solution 30 ml vials x12 Amo Lens Plus Ocupure saline solution 360 ml Boston Advance/Bausch & Lomb cleaner solution 30 ml Boston Advance/Bausch & Lomb cleaner solution 120 ml I-Clean Contact Lens Cleaner solution 50 ml Synergi Multipurpose Contact Lens solution 250 ml x3 (3 month pack) Return to index

Developed by Ipswich Hospital NHS Trust and Ipswich and East Suffolk Clinical Commissioning Group. Joint formulary - Ophthalmology

Developed by Ipswich Hospital NHS Trust and Ipswich and East Suffolk Clinical Commissioning Group. Joint formulary - Ophthalmology Developed by Ipswich Hospital NHS Trust and Ipswich and East Suffolk Clinical Commissioning Group. Document type and title: Joint formulary - Ophthalmology Authorised document folder: New or replacing

More information

BNF CHAPTER 11: EYE 1 January 2018

BNF CHAPTER 11: EYE 1 January 2018 BNF CHAPTER 11: EYE 1 BNF 11.3.1 ANTIBACTERIALS First Choice. Broad spectrum. Chloramphenicol 0.5% Eye Drops Administration Alternative Administration Eye drops, apply 1 drop at least every 2 hours then

More information

11.Eye Administration of drugs to the eye. Eye drops. Eye ointments. Prescribing of Unlicensed Eye Products

11.Eye Administration of drugs to the eye. Eye drops. Eye ointments. Prescribing of Unlicensed Eye Products 1 11.Eye 11.1 - Administration of drugs to the eye Eye-drop dispenser devices (Compleye, Opticare, Opticare Arthro 5, Opticare Arthro 10) are available to aid the instillation of eye drops from plastic

More information

11.Eye Administration of drugs to the eye. Eye drops. Eye ointments. Prescribing of Unlicensed Eye Products

11.Eye Administration of drugs to the eye. Eye drops. Eye ointments. Prescribing of Unlicensed Eye Products 1 11.Eye 11.1 - Administration of drugs to the eye Eye-drop dispenser devices (Compleye, Opticare, Opticare Arthro 5, Opticare Arthro 10) are available to aid the instillation of eye drops from plastic

More information

Drugs That May Be Used by Certain Optometrists

Drugs That May Be Used by Certain Optometrists Drugs That May Be Used by Certain Optometrists Approved drugs. (a) Administration and prescription of pharmaceutical agents. Optometrists who are certified to prescribe and administer pharmaceutical agents

More information

Ophthalmic Special Order Products, General Principles

Ophthalmic Special Order Products, General Principles Ophthalmic Special Order Products, General Principles When clinically appropriate and available, licensed products should always be prescribed and dispensed in preference to unlicensed products. Where

More information

Ophthalmic Special Order Products, General Principles

Ophthalmic Special Order Products, General Principles Ophthalmic Special Order Products, General Principles When clinically appropriate and available, licensed products should always be prescribed and dispensed in preference to unlicensed products. Certain

More information

CLINICAL OPHTHALMIC THERAPEUTIC PHARMACEUTICAL AGENTS (TPA) QUICK REFERENCE GUIDE

CLINICAL OPHTHALMIC THERAPEUTIC PHARMACEUTICAL AGENTS (TPA) QUICK REFERENCE GUIDE F- 15 CLINICAL OPHTHALMIC THERAPEUTIC PHARMACEUTICAL AGENTS (TPA) QUICK REFERENCE GUIDE Assembled by: Tim Maillet, OD, BSc NSAO Practice Innovations Committee Chairperson September 2009 F- 16 Ocular Allergies

More information

11 Eye. regarding this product in this setting. As a result we cannot recommend its use within NHSScotland.

11 Eye. regarding this product in this setting. As a result we cannot recommend its use within NHSScotland. Recommendations from the Lothian Formulary Committee (FC) following Scottish Medicines Consortium (SMC) advice, NICE MTA advice, (FAF3) unlicensed and off-label medicines and (FAF2) medicines not considered

More information

Data from the recent therapeutic

Data from the recent therapeutic Getting started in therapeutics Part 8a What drugs will I prescribe and supply? Continuing our series on therapeutics in practice, Lucy Titcomb and Professor John Lawrenson review the range of ophthalmic

More information

11 Eye. systemic disease or both eyes are affected (or 1 eye is affected if the second eye has poor visual acuity) and

11 Eye. systemic disease or both eyes are affected (or 1 eye is affected if the second eye has poor visual acuity) and Recommendations from the Lothian Formulary Committee (FC) following Scottish Medicines Consortium (SMC) advice, NICE MTA advice, (FAF3) unlicensed and off-label medicines and (FAF2) medicines not considered

More information

South East London Area Prescribing Committee Chronic Open Angle Glaucoma and Ocular Hypertension Treatment Pathway

South East London Area Prescribing Committee Chronic Open Angle Glaucoma and Ocular Hypertension Treatment Pathway Proceed to 2 nd line treatment if further reduction in IOP required and there is good response to PGAs or (& no South East London Area Prescribing Committee Chronic Open Angle Glaucoma and Ocular Hypertension

More information

Dry Eye Prescribing Guidelines

Dry Eye Prescribing Guidelines Dry Eye Prescribing Guidelines Amendment History VERSION DATE AMENDMENT HISTORY V1.0 2011 Comments V1.1 2013 Updated V1.1 2017 Draft Updated Thealoz Duo replaces carmellose Optive in severe dry eye on

More information

A Compendium of Product information & Indicative manufacturer s prices

A Compendium of Product information & Indicative manufacturer s prices A Compendium of Product information & Indicative manufacturer s prices (March 2012) for 28-days treatment with commonly used -free eye drops & ointments This information has been produced for prescribing

More information

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC)

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Guidelines for the medical treatment of chronic open angle glaucoma and ocular hypertension Summary: DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Diagnosis and management of ocular hypertension (OHT)

More information

MECS and Prescribing. Jane Bell BSc FCOptom, DipTpIP, Dip Glauc

MECS and Prescribing. Jane Bell BSc FCOptom, DipTpIP, Dip Glauc MECS and Prescribing Jane Bell BSc FCOptom, DipTpIP, Dip Glauc Discussion House Rules Open discussion with everyone participating Respect the view of others; do not criticise or judge There are no right

More information

Volume 9; Number 6 May 2015 PRESCRIBING FOR CHRONIC OPEN ANGLE GLAUCOMA (COAG) AND OCULAR HYPERTENSION (OHT)

Volume 9; Number 6 May 2015 PRESCRIBING FOR CHRONIC OPEN ANGLE GLAUCOMA (COAG) AND OCULAR HYPERTENSION (OHT) Greater East Midlands Commissioning Support Unit in association with Lincolnshire Clinical Commissioning Groups, Lincolnshire Community Health Services, United Lincolnshire Hospitals Trust and Lincolnshire

More information

Optometrists Formulary. Compiled and produced by Professor John Lawrenson Division of Optometry and Visual Science City University London

Optometrists Formulary. Compiled and produced by Professor John Lawrenson Division of Optometry and Visual Science City University London Optometrists Formulary Compiled and produced by Professor John Lawrenson Division of Optometry and Visual Science City University London August 2016 Contents Optometrists formulary background notes 1 Acetazolamide

More information

MODULE 10:12 COURSE CODE: C-5848

MODULE 10:12 COURSE CODE: C-5848 30 MODULE 10:12 COURSE CODE: C-5848 Drugs used in the treatment of dry eye syndrome, anti-inflammatory drugs and topical anti-allergy drugs Elaine Mann This article will cover the factors causing dry eye

More information

REFERENCE GUIDE FOR OPHTHALMIC PREPARATIONS AVAILABLE FOR USE BY ALL OPTOMETRISTS*

REFERENCE GUIDE FOR OPHTHALMIC PREPARATIONS AVAILABLE FOR USE BY ALL OPTOMETRISTS* APPENDIX III REFERENCE GUIDE FOR OPHTHALMIC PREPARATIONS AVAILABLE FOR USE BY ALL OPTOMETRISTS* *Excluding preparations for use in the treatment of dry eye 1 Antazoline Sulphate (P) For the temporary relief

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 28 May 2008

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 28 May 2008 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 28 May 2008 COSOPT 20 mg/5 mg/ml, eye drops, solution in single dose container Box of 60 0.2 ml single dose containers

More information

Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D.

Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D. Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D. Direct agonists Indirect agonist Antagonist Direct agonist: Miosis, accomodation

More information

4/24/2018. Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D.

4/24/2018. Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D. Miotics, Glaucoma Meds, Antibiotics, Corticosteroids, NSAIDS Antivirals, Antihistamines Christopher J. McDevitt, M.D. Direct agonists Indirect agonist Antagonist Direct agonist: Miosis, accomodation Increase

More information

Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj.

Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj. Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj. 3-Ceftriaxone 250mg & Sulbactam 125mg Inj. 4-Ceftriaxone 125mg & Sulbactam 62.5mg Inj. 5-Rabeprazole

More information

East and North Hertfordshire treatment pathway for primary open angle glaucoma and ocular hypertension in adults

East and North Hertfordshire treatment pathway for primary open angle glaucoma and ocular hypertension in adults East and North Hertfordshire treatment pathway for primary open angle glaucoma and ocular hypertension in adults Introduction Glaucoma is a group of eye diseases causing optic nerve damage. In most cases

More information

DQSA Listening Session June 6, 2017

DQSA Listening Session June 6, 2017 DQSA Listening Session June 6, 2017 I am Allison Madson, manager of regulatory affairs, for the American Society of Cataract and Refractive Surgery. ASCRS is a medical specialty society representing nearly

More information

Optometrists Formulary

Optometrists Formulary 1 Optometrists Formulary Compiled and Produced by Professor John Lawrenson, Division of Optometry and Visual Science City University London October 2012 2 Acetazolamide 9 Acetylcysteine 11 Aciclovir 13

More information

ACETAZOLAMIDE (a-seet-a-zole-a-mide)

ACETAZOLAMIDE (a-seet-a-zole-a-mide) EYES Medicines for glaucoma Other medicines for glaucoma Active ingredients (generic names) ACETAZOLAMIDE (a-seet-a-zole-a-mide) Common brands include: Diamox, Glaumox What it is used for Acute glaucoma

More information

OPHTHALMIC MEDICATIONS

OPHTHALMIC MEDICATIONS OPHTHALMIC MEDICATIONS Ally Cuddy, PharmD PGY1 Pharmacy Resident September 7, 2017 AMERICAN ACADEMY OF OPHTHALMOLOGY American Academy of Ophthalmology. 2015. CASE #1 TR is a 76 YOM with no significant

More information

PATIENT CASE HISTORY. General Health Medications Allergies

PATIENT CASE HISTORY. General Health Medications Allergies OCULAR PHARMACOLOGY What I Need to Know Before I Medicate A Patient Lynn Lawrence, CPOT, ABOC, COA ROLE of the ASSISTANT AND TECHNICIAN Accurate documentation/recording Patient Education can assist in

More information

Pharma X Consultancy Inc. Inventory List

Pharma X Consultancy Inc. Inventory List Pharma X Consultancy Inc. Inventory List Location: Pharma X Consultancy Inc 2 Aceclofenac 100mg Tablets 60S 1205 ID Aciclovir 200mg Tablets 25S 1213 Aciclovir 400mg Tablets 56S 1214 Aciclovir 5% Cream

More information

Release of the 2013/14 Invitation to Tender

Release of the 2013/14 Invitation to Tender 07 November 2013 Release of the 2013/14 Invitation to Tender The 2013/14 Invitation to Tender (2013/14 ITT) has been distributed today via the electronic tender (etender) system. If you do not receive

More information

Page 1 RED EYES. conjunctivitis keratitis episcleritis / scleritis. Frank Larkin Moorfields Eye Hospital. acute glaucoma anterior uveitis

Page 1 RED EYES. conjunctivitis keratitis episcleritis / scleritis. Frank Larkin Moorfields Eye Hospital. acute glaucoma anterior uveitis The RED EYE and ALLERGIC EYE DISEASE DIAGNOSIS & MANAGEMENT Frank Larkin Moorfields Eye Hospital RED EYES conjunctivitis keratitis episcleritis / scleritis acute glaucoma anterior uveitis post-op. / trauma

More information

Scottish Dry Eye Guidelines

Scottish Dry Eye Guidelines Scottish Dry Eye Guidelines VERSION 1.1 September 2018 Scottish Dry Eye Guidelines, version 1.1, September 2018 Contents Contents 1 Introduction 1 Dry Eye Working Group 1 Contributors to Dry Eye Working

More information

OCULAR PHARMACOLOGY GLAUCOMA. increased intraocular pressure. normally mm Hg. when to Tx no fixed level.

OCULAR PHARMACOLOGY GLAUCOMA. increased intraocular pressure. normally mm Hg. when to Tx no fixed level. OCULAR PHARMACOLOGY GLAUCOMA increased intraocular pressure normally 12 20 mm Hg. when to Tx no fixed level. literature sets ~21 mm Hg as upper limit of normal. some safe at 30 mm Hg some may have damage

More information

OPR OPTOMETRIC PRACTICE REFERENCE STANDARDS OF PRACTICE

OPR OPTOMETRIC PRACTICE REFERENCE STANDARDS OF PRACTICE OPR OPTOMETRIC PRACTICE REFERENCE The best eye health and vision for everyone in Ontario, through excellence in optometric care. Publishing History The Guide to the Clinical Practice of Optometry FIRST

More information

Advance Notification of Amendments to the April 2015 Drug Tariff

Advance Notification of Amendments to the April 2015 Drug Tariff Advance Notification of Amendments to the April 2015 Drug Tariff ADDITIONS Part I - Drugs And Preparations Drug Qty Price Chlorambucil 2mg tablets 25 40.51 A Melphalan 2mg tablets 25 42.88 A Part III Appliances

More information

Dry Eye Prescribing Guidelines

Dry Eye Prescribing Guidelines Dry Eye Prescribing Guidelines Mike Quinlan Jag Sangha Minesh Parbat Alison Whitlock Shamina Asif Charles Barlow Mohit Mandiratta Authors Consultant Ophthalmologist, DGOH Pharmaceutical Adviser, Dudley

More information

Completed Clinical Research Trials Monte Dirks, M.D.

Completed Clinical Research Trials Monte Dirks, M.D. Completed Clinical Research Trials Monte Dirks, M.D. Monte Dirks, M.D. - Primary Investigator Norfloxacin -Merck (1986) Safety and efficacy of norfloxacin vs. tobramycin in the treatment of external ocular

More information

A. Incorrect! Acetazolamide is a carbonic anhydrase inhibitor given orally or by intravenous injection.

A. Incorrect! Acetazolamide is a carbonic anhydrase inhibitor given orally or by intravenous injection. Pharmacology - Problem Drill 20: Drugs that Treat Glaucoma Question No. 1 of 10 1. is a topical carbonic anhydrase inhibitor. Question #01 (A) Acetazolamide (B) Clonidine (C) Dorzolamide (D) Apraclonidine

More information

Advance Notification of Amendments to the March 2017 Drug Tariff

Advance Notification of Amendments to the March 2017 Drug Tariff Advance Notification of Amendments to the March 2017 Drug Tariff ADDITIONS Part I - Drugs And Preparations Special Container Drug Qty Price Acetylcysteine 600mg capsules 30 39.95 A Caffeine citrate 50mg/5ml

More information

BNF/BNFC Chapter 11 Eye

BNF/BNFC Chapter 11 Eye NF/NF hapter 11 ye irections for questions 1 to 8. ach of the questions or incomplete statements in this section is followed by five suggested answers. Select the best answer in each case. 1. Which of

More information

Dry Eye Prescribing Guidelines

Dry Eye Prescribing Guidelines Dry Eye Prescribing Guidelines Amendment History VERSION DATE AMENDMENT HISTORY V1.0 2011 Comments V1.1 2013 Updated V1.1 2017 Draft Updated Thealoz Duo replaces carmellose Optive in severe dry eye on

More information

Dry Eye Syndrome Prescribing Guidelines

Dry Eye Syndrome Prescribing Guidelines Dry Eye Syndrome Prescribing Guidelines Dry Eye Syndrome is a group of disorders of the ocular surface related to tear film abnormality, associated with ocular discomfort, visual symptoms and objective

More information

Volume 4; Number 4 April 2010 PRESCRIBING GUIDANCE FOR HAY FEVER: SPRING / SUMMER 2010

Volume 4; Number 4 April 2010 PRESCRIBING GUIDANCE FOR HAY FEVER: SPRING / SUMMER 2010 Volume 4; Number 4 April 2010 PRESCRIBING GUIDANCE FOR HAY FEVER: SPRING / SUMMER 2010 PACEF Recommendations Recommended medicines remain the same as in recent years: Non-sedating antihistamines: generic

More information

Treatments for Open-Angle Glaucoma. A Review of the Research for Adults

Treatments for Open-Angle Glaucoma. A Review of the Research for Adults Treatments for Open-Angle Glaucoma A Review of the Research for Adults Is This Information Right for Me? Yes, this information is for you if: Your eye doctor has said that you have open-angle glaucoma,

More information

ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS

ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS SR. NO 1 ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS Paracetamol 500 mg, Phenylephrine HCL 5 mg With Chlorpheniramine Maleate 2 mg & Caffeine 30 mg Tablets 2 Salbutamol Tablets BP 2 mg 3 Salbutamol Tablets

More information

Financial Disclosure. Prostaglandin Analogs (PGs) The Glaucoma Grab Bag: Practical Guidelines for Effective Glaucoma Therapy

Financial Disclosure. Prostaglandin Analogs (PGs) The Glaucoma Grab Bag: Practical Guidelines for Effective Glaucoma Therapy The Glaucoma Grab Bag: Practical Guidelines for Effective Glaucoma Therapy Danica J. Marrelli, OD, FAAO University of Houston College of Optometry Financial Disclosure I have received I have received speaking

More information

VI.2.2 Summary of treatment benefits

VI.2.2 Summary of treatment benefits EU-Risk Management Plan for Bimatoprost V01 aetiology), both OAG and ACG can be secondary conditions. Secondary glaucoma refers to any case in which another disorder (e.g. injury, inflammation, vascular

More information

Elements for a Public Summary. Overview of disease epidemiology

Elements for a Public Summary. Overview of disease epidemiology VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Epidemiology of the disease Incidence and prevalence Increased pressure in the eye occurs in more than 100 million people, and

More information

Local Minor Ailment Service Formulary

Local Minor Ailment Service Formulary Local Minor Ailment Service Formulary Pharmacy and Prescribing Team Revised 2013 Reference: MAS Version 1 Supersedes: None Page 1 of 17 Date approved: 25 th October 2013 Review date: October 2016 Contents

More information

10 Musculoskeletal and Joint Diseases

10 Musculoskeletal and Joint Diseases 10 Musculoskeletal and Joint Diseases To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and British Society of Rheumatology guidelines and guidance

More information

TA Number. TA Link. Annotation

TA Number. TA Link. Annotation Report generated from BNF with QVH Formulary provided by FormularyComplete (www.pharmpress.com). Accessed 09 10 2015 Title Formulary Status Section TA Number TA Link Annotation Almond Oil 12.1 Drugs acting

More information

Volume 4; Number 6 May 2010

Volume 4; Number 6 May 2010 Volume 4; Number 6 May 2010 What s new this month: Local ophthalmologists have been working with PACEF to develop a formulary of eye preparations for the treatment of open angle and raised intra ocular

More information

Learn Connect Succeed. JCAHPO Regional Meetings 2017

Learn Connect Succeed. JCAHPO Regional Meetings 2017 Learn Connect Succeed JCAHPO Regional Meetings 2017 Financial Disclosure Advanced Ophthalmic Pharmacology: A Practical Approach I have no financial interests in this presentation Trade and generic names

More information

Chapter 12 Ear, Nose and Oropharynx

Chapter 12 Ear, Nose and Oropharynx Chapter 12 page number 1 Chapter 12 Ear, Nose and Oropharynx First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both

More information

Abbreviated Update: Ophthalmic Glaucoma Agents

Abbreviated Update: Ophthalmic Glaucoma Agents Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-945-5220 Fax 503-947-1119 Abbreviated Update: Ophthalmic Glaucoma Agents Month/Year

More information

LIST OF MEDICINE FOR OUTPATIENT DEPARTMENT (O.P.D) S. No.

LIST OF MEDICINE FOR OUTPATIENT DEPARTMENT (O.P.D) S. No. Category C LIST OF MEDICINE FOR OUTPATIENT DEPARTMENT (O.P.D) S. 01 Dexamethasone +Chloramphenicol Eye drop 30000 02. 10000 Tobramycin 0.3% eye drop 03. Moxifloxacin Eye drop 7200 04. Hydroxypropyl Methyl

More information

Re-submission. Scottish Medicines Consortium. Olopatadine 1mg/ml eye drops, solution (Opatanol ) No. 59/03) Alcon Laboratories (UK) Ltd

Re-submission. Scottish Medicines Consortium. Olopatadine 1mg/ml eye drops, solution (Opatanol ) No. 59/03) Alcon Laboratories (UK) Ltd Scottish Medicines Consortium Re-submission Olopatadine 1mg/ml eye drops, solution (Opatanol ) No. 59/03) Alcon Laboratories (UK) Ltd 9 December 2005 The Scottish Medicines Consortium (SMC) has completed

More information

UPLB-S , SUPPLY AND DELIVERY OF DRUGS AND MEDICINES TECHNICAL SPECIFICATION FOR THE PUBLIC BIDDING OF: OPENING OF BIDS:

UPLB-S , SUPPLY AND DELIVERY OF DRUGS AND MEDICINES TECHNICAL SPECIFICATION FOR THE PUBLIC BIDDING OF: OPENING OF BIDS: 1 1 0.3 Sodium Chloride with 5% Dextrose in 1000 ml in plastic bottle 2 0.3 Sodium Chloride With 5% Dextrose In 500 ml In Plastic Bottle 3 0.9 Sodium Chloride with 5% Dextrose 1000 ml in plastic bottle

More information

12.1 DRUGS ACTING ON THE EAR

12.1 DRUGS ACTING ON THE EAR 12.1 DRUGS ACTING ON THE EAR Anti-inflammatory/anti-infective preparations These preparations usually contain a corticosteroid either alone or with an antibacterial agent. Betamethasone 0.1% ear, eye,

More information

nepafenac 1mg/mL eye drops, suspension (Nevanac ) SMC No. (813/12) Alcon Laboratories (UK) Ltd

nepafenac 1mg/mL eye drops, suspension (Nevanac ) SMC No. (813/12) Alcon Laboratories (UK) Ltd nepafenac 1mg/mL eye drops, suspension (Nevanac ) SMC No. (813/12) Alcon Laboratories (UK) Ltd 05 October 2012 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product

More information

Chapter 12 Ear, Nose and Oropharynx

Chapter 12 Ear, Nose and Oropharynx Chapter 12 page number 1 Chapter 12 Ear, Nose and Oropharynx First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both

More information

The use of eye drops and ointments in A&E

The use of eye drops and ointments in A&E Janet Marsden MSc, BSc (Hons), RGN, MIMgt is Senior Lecturer, Manchester Metropolitan University, and Chair of the RCN Ophthalmic Forum Janet Marsden describes the various eye drops and ointments commonly

More information

Ophthalmological preparations

Ophthalmological preparations Ophthalmological preparations Administration of eye preparations Preparations for the eye should be sterile when issued. Use of single-application containers is preferable; multiple-application preparations

More information

Advance Notification of Amendments to the December 2018 Drug Tariff

Advance Notification of Amendments to the December 2018 Drug Tariff Advance Notification of Amendments to the December 2018 Drug Tariff ADDITIONS Zero Discount Fondaparinux sodium solution for injection pre-filled (ALL) FreeStyle Libre Sensor Oxygen CD cylinder Oxygen

More information

Calgary Long Term Care Formulary

Calgary Long Term Care Formulary Page 1 of 10 Calgary Long Term Care Formulary Pharmacy & Therapeutics November 2018 Highlights https://www.albertahealthservices.ca/info/page4071.aspx Page 2 of 10 Contents November 2018... 3 Formulary

More information

Long Term Care Formulary RS 14. RESTRICTED STATUS Topical Medical Treatment of Glaucoma 1 of 5

Long Term Care Formulary RS 14. RESTRICTED STATUS Topical Medical Treatment of Glaucoma 1 of 5 RESTRICTED STATUS Topical Medical Treatment of Glaucoma 1 of 5 PREAMBLE Significance: Glaucoma occurs in 1-2% of white people aged over 40 years, rising to 5% at 70 years and exponentially with advancing

More information

BrightFocus Foundation is the new name for American Health Assistance Foundation.

BrightFocus Foundation is the new name for American Health Assistance Foundation. In this section, you will find the following: Glaucoma Medications Laser Therapies Conventional Surgical Procedures In the second section, you will find information on how to search for potential treatments

More information

MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY

MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY Eye & Ear Anti-Inflammatory Disorders P & T DATE 9/12/2017 THERAPEUTIC CLASS Topical Anti-Inflammatory Agents REVIEW HISTORY

More information

BETAGAN Allergan Levobunolol HCl Glaucoma Therapy

BETAGAN Allergan Levobunolol HCl Glaucoma Therapy BETAGAN Allergan Levobunolol HCl Glaucoma Therapy Action And Clinical Pharmacology: Levobunolol is a noncardioselective beta- adrenoceptor antagonist, equipotent at both beta1 and beta2 receptors. Levobunolol

More information

INDICATIONS ACULAR 0,5 % is indicated for the relief of inflammation following ocular surgery.

INDICATIONS ACULAR 0,5 % is indicated for the relief of inflammation following ocular surgery. Page 1 of 5 SCHEDULING STATUS Schedule 3 PROPRIETARY NAME (AND DOSAGE FORM) ACULAR 0,5 % COMPOSITION ACULAR 0,5 % contains: Preservatives: Benzalkonium chloride 0,01 % m/v Disodium edetate 0,1 % m/v PHARMACOLOGICAL

More information

Serious Eye diseases, New treatments. Mr. M. Usman Saeed MBBS, FRCS, FRCOphth Consultant Ophthalmologist

Serious Eye diseases, New treatments. Mr. M. Usman Saeed MBBS, FRCS, FRCOphth Consultant Ophthalmologist Serious Eye diseases, New treatments Mr. M. Usman Saeed MBBS, FRCS, FRCOphth Consultant Ophthalmologist 5 major causes of loss of vision Cataracts Glaucoma Macular degeneration Retinal Vein occlusions

More information

Mild NPDR. Moderate NPDR. Severe NPDR

Mild NPDR. Moderate NPDR. Severe NPDR Diabetic retinopathy Diabetic retinopathy is the most common cause of blindness in adults aged 35-65 years-old. Hyperglycaemia is thought to cause increased retinal blood flow and abnormal metabolism in

More information

PHARMACEUTICALS. SEAL OF EXCELLENCE Henry Schein. Pharmaceuticals A - C D - H I - P P - Z ALL PRICES

PHARMACEUTICALS. SEAL OF EXCELLENCE Henry Schein. Pharmaceuticals A - C D - H I - P P - Z ALL PRICES SEAL OF EXCELLENCE Henry Schein Pharmaceuticals 343-348 A - C 344-345 D - H 345-346 I - P 346-347 P - Z 347-348 PHARMACEUTICALS info@henryscheinmedical.co.uk phone 0800 0304169 343 Pharmaceuticals Pharmaceuticals

More information

We are one of the renowned manufacturers of ophthalmic products such as intraocular lenses, ophthalmic drugs, suture needle and instruments.

We are one of the renowned manufacturers of ophthalmic products such as intraocular lenses, ophthalmic drugs, suture needle and instruments. We are one of the renowned manufacturers of ophthalmic products such as intraocular lenses, ophthalmic drugs, suture needle and instruments. Our consistency in providing improved quality products has brought

More information

Supply should only occur if requesting signature is on approved list held by the issuing pharmacy

Supply should only occur if requesting signature is on approved list held by the issuing pharmacy Trust Approved Drugs List March 2016 The following is the list of drugs that are approved by the EEAST Medicines Management Group for use by EEAST clinical staff. Pharmacies are advised that this is the

More information

8 USE IN SPECIFIC POPULATIONS Patients with Open-Angle Glaucoma or Ocular Hypertension

8 USE IN SPECIFIC POPULATIONS Patients with Open-Angle Glaucoma or Ocular Hypertension 3 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Isopto Carpine safely and effectively. See full prescribing information for Isopto Carpine. Isopto

More information

Abbreviated Class Update: Ophthalmics, Glaucoma agents. Month/Year of Review: August 2012 End date of literature search: June 2012

Abbreviated Class Update: Ophthalmics, Glaucoma agents. Month/Year of Review: August 2012 End date of literature search: June 2012 Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

2019 Catalog Hospital and Ophthalmology Products and Services

2019 Catalog Hospital and Ophthalmology Products and Services 209 Catalog Hospital and Ophthalmology Products and Services Ophthalmology Ophthalmology Services. No prescription required No minimum order quantity New formulations are continually added to our portfolio.

More information

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and 5 Infections To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and Southend University Hospital, Antibiotic Guidelines Index 5.1 Antibacterial drugs

More information

Ophthalmic Medication Review and Update. Scott Ensor, OD, MS Associate Professor Southern College of Optometry

Ophthalmic Medication Review and Update. Scott Ensor, OD, MS Associate Professor Southern College of Optometry Ophthalmic Medication Review and Update Scott Ensor, OD, MS Associate Professor Southern College of Optometry Financial Disclosures None! About Me Native Memphian 2001 SCO Graduate Primary Care Residency

More information

Vision Health: Conditions, Disorders & Treatments GLAUCOMA

Vision Health: Conditions, Disorders & Treatments GLAUCOMA Vision Health: Conditions, Disorders & Treatments GLAUCOMA Glaucoma is a disease of the optic nerve, which transmits the images you see from the eye to the brain. The optic nerve is made up of many nerve

More information

Ocular Medication and Compliance

Ocular Medication and Compliance Ocular Medication and Compliance Consultant for Alcon Disclosures CECELIA KOETTING, OD FAAO VIRGINIA EYE CONSULTANTS VOA CONFERENCE NORFOLK 2018 Virginia Optometry License Generic vs Brand Name Every state

More information

GLAUCOMA (2006) PHILIPPINE GLAUCOMA SOCIETY

GLAUCOMA (2006) PHILIPPINE GLAUCOMA SOCIETY GLAUCOMA (2006) PHILIPPINE GLAUCOMA SOCIETY CPM 9 TH EDITION Philippine Glaucoma Society (PGS) Correspondence to: Eye Referral Center, T. M. Kalaw Street, Ermita, Manila Telephone: 524-7119/525-9360 Mobile:

More information

Concentrations and Dilutions INTRODUCTION. L earning Objectives CHAPTER

Concentrations and Dilutions INTRODUCTION. L earning Objectives CHAPTER CHAPTER 6 Concentrations and Dilutions L earning Objectives After completing this chapter, you should be able to: INTRODUCTION Concentrations of many pharmaceutical preparations are expressed as a percent

More information

12: Ear, nose, and oropharynx

12: Ear, nose, and oropharynx Original Date of issue: 30/03/2006 Last eviewed: 01/05/2011 Version:2 Page 1 of 5 12: Ear, nose, and oropharynx 12.1 Drugs acting on the ear 12.1.1 Otitis externa Astringent preparations Aluminium Acetate

More information

Get a grip on your glaucoma Booklet 1

Get a grip on your glaucoma Booklet 1 Information for Patients Glaucoma services Welcome! Get a grip on your glaucoma Booklet 1 Group-based Glaucoma information Course Session 1 What happens in session 1? Finding out what questions you have

More information

This application applies to the following medicines for ophthalmic use:

This application applies to the following medicines for ophthalmic use: 10 January 2007 Medicines Classification Committee MedSafe Ministry of Health PO Box 5013 WELLINGTON RE: SUBMISSION FOR RE-CLASSIFICATION OF PHARMACY-ONLY EYE PREPARATIONS TO ALLOW SUPPLY BY OPTOMETRIST

More information

Intravitreal Injection

Intravitreal Injection for patients Eye Clinic Ipswich Hospital Tel: 01473 703230 Intravitreal Injection What is an intravitreal injection? An intravitreal injection is the injection of a drug into the vitreous body (the jelly

More information

AETNA BETTER HEALTH January 2017 Formulary Change(s)

AETNA BETTER HEALTH January 2017 Formulary Change(s) AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on February 1, 2017 Drug Name, Strength, Dosage Form IVERMECTIN 3 MG TABLET

More information

Outline. Financial Disclosures. Outline. Importance. Importance 2/13/2014

Outline. Financial Disclosures. Outline. Importance. Importance 2/13/2014 Brad Genereux, OD February 8 th, 2014 Anti-infective (bacterial, viral, fungal) Financial Disclosures No disclosures Importance Know drugs you re administering to patient Patient education Reactions Triage

More information

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M % June 2016 On 13th May, the DH announced that there would be reductions to Category M prices from June until September. http://psnc.org.uk/our-news/contractor-notice-category-m-price-reduction/ This has

More information

Rajasthan Medical Services Corporation Limited, Jaipur

Rajasthan Medical Services Corporation Limited, Jaipur Rajasthan Medical Services Corporation Limited, Jaipur List of Drugs- Purchase order placed to successful Bidders Tendered on 05/07/2011 S.No. Name of Drug 1 Atropine Sulphate Injection 0.6 mg /ml (SC/IM/IV

More information

Class Update with New Drug Evaluation: Glaucoma Drugs

Class Update with New Drug Evaluation: Glaucoma Drugs Class Update with New Drug Evaluation: Glaucoma Drugs Date of Review: May 2018 Date of Last Review: January 2015 End Date of Literature Search: 02/26/2018 Generic Name: latanoprostene bunod Brand Name

More information

Martindale Pharma is a UK pharmaceutical manufacturing company supplying niche products to over 50 countries worldwide.

Martindale Pharma is a UK pharmaceutical manufacturing company supplying niche products to over 50 countries worldwide. INTERNATIONAL Martindale Pharma is a UK pharmaceutical manufacturing company supplying niche products to over 50 countries worldwide. Our vision Making Lives Better drives every action and decision of

More information

Medical Treatment in Pediatric Glaucoma

Medical Treatment in Pediatric Glaucoma Medical Treatment in Pediatric Glaucoma By Nader Bayoumi, MD Lecturer of Ophthalmology Ophthalmology Department Alexandria University Alexandria, Egypt ESG 2012 Pediatric glaucoma is a surgical disease

More information

Advance Notification of Amendments to the March 2018 Drug Tariff

Advance Notification of Amendments to the March 2018 Drug Tariff Advance Notification of Amendments to the March 2018 Drug Tariff ADDITIONS Zero Discount Terbutaline 2.5mg/5ml solution for injection ampoules Part I - Drugs And Preparations Special Container * This pack

More information

Class Update with New Drug Evaluation: Glaucoma Drugs

Class Update with New Drug Evaluation: Glaucoma Drugs Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria Medications that require Step Therapy (ST) require trial and failure of preferred formulary agents prior to their authorization. If the prerequisite medications have been filled within the specified time

More information